CMS proposal limits coverage of drug to help diagnose Alzheimer’s.

By: Chris Placitella @ Jul 07, 2013

On Wednesday, the Centers for Medicare & Medicaid Services proposed that “Medicare will pay the costs of brain imaging that uses a Eli Lilly & Co. drug to help diagnose Alzheimer’s disease only for patients participating in approved clinical studies,” Bloomberg News (7/4, Lopatto) reported. According to regulators, “there isn’t enough evidence to show […]

https://www.chrisplacitella.com/2013/07/07/cms-proposal-limits-coverage-of-drug-to-help-diagnose-alzheimers/

Brought to you by:

CPR Law

2001 Market Street, Suite 2900
Philadelphia,
Pennsalvania
19103

Phone: (215) 567-3500
https://cprlaw.com/pennsylvania/
https://cprlaw.com/pa/philadelphia/

Disclaimer: The law firm of Cohen, Placitella & Roth, P.C. only provides legal advice after it has entered into an attorney-client relationship, which this website specifically does not create. Only after having entered into a written, signed agreement with the law firm of Cohen, Placitella & Roth, P.C. will an attorney-client relationship have been created. It is imperative that any action taken be done on the advice of counsel. Because every case is different, the descriptions of awards and cases previously handled are not meant to be a guarantee of success. Cohen, Placitella & Roth, a National Personal Injury, Mesothelioma, Birth Injury and Medical Malpractice Law Firm with Offices in Pennsylvania and New Jersey

CMS proposal limits coverage of drug to help diagnose Alzheimer’s.

Archives

Categories